Fundraising FoxBreakout Ventures — 2022 Investments
6 investments dated 2022 · listed companies and verified rows first · show all
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Founder)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardJack Fuchs(Director, Promoter)in
Board seatLindy Fishburne· per SEC Form D
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsDolby Family VenturesEMV Capital+6 more
Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.
BiotechClimate TechFoodTechNew MaterialsAlameda, US
Scott Franklin(Executive Officer, Director)inCharles Dimmler(Executive Officer, Director)inJohn Krzywicki(CEO)inLayla Ward(CFO)inCasey Lippmeier(CTO)inLeon Parker(SVP, Molecular Biology)in
Board seatJulia Moore· per SEC Form D
Co-investorsBaruch Future VenturesCavallo VenturesKdT VenturesPlug and Play VenturesViking GlobalBuilders VC+5 more
Surf Bio is a preclinical biopharmaceutical company developing its SnapShot technology, which uses a proprietary polymer to create ultra-high-concentration antibody and biologic formulations (600+ mg/mL, doses over 1,000 mg) for delivery via a standard autoinjector.
BiotechDeep TechHealthtechPalo Alto, US
Jennifer Schneider(Executive Officer, Director)Ben Askew(Director)Bryan Mazlish(Chief Executive Officer, co-founder)inJennifer Schneider, MD(Co-founder, President & Chief Medical Officer)in
Board seatLindy Fishburne· per SEC Form D
Co-investorsPantera Capital
En Plus One Bio develops synthesis and manufacturing technology for RNA therapeutics, focused on producing high-purity long RNA with higher cycle efficiencies and novel chemical modifications.
BiotechDeep TechWatertown, US
Daniel Ahlstedt(Executive Officer, Director)inJonathan Rittichier(Founder)inDaniel Wiegand(Founder)George M. Church(Founder)
BoardPaxton Major(Director)inAndrew Lee(Director)in
Co-investorsCoatue ManagementNorthpond Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.